This federal litigation is for people who say Wegovy (or another GLP-1 drug) contributed to them developing NAION
Oral Wegovy pill and Rybelsus, injectable Wegovy and Ozempic, they all have same active ingredient called Semaglutide which is a GLP-1 agonist, used for treatment of diabetes as well as weight loss
Weight Loss Medication is Not Suitable for Everyone Semaglutide isnt recommended for people with certain health conditions, including thyroid disorders, pancreatitis, or a history of severe gastrointestinal issues
Corrado recommends aiming for roughly 1.2 to 1.6 grams of protein per kilogram of body weight about 108 to 144 grams daily for someone who weighs 200 pounds
It is not a drug, dietary supplement, or medical product, and is not for human consumption, diagnosis, or treatment
Long-term use and patient expectations GLP-1 therapy should be considered a long-term treatment